International researchers led by Israel’s Weizmann Institute and Hebrew University of Jerusalem has developed an experimental blood test that detects early-stage breast cancer with 95% accuracy for localized tumors under 2cm. It also outperforms existing tests for recurrence after treatment.
https://www.timesofisrael.com/israeli-blood-test-detects-early-breast-cancer-with-95-accuracy/